Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways

Author:

Wen Bingjian,Zhang Chengcheng,Zhou Jingwen,Zhang Zhengyan,Che Qishi,Cao Hua,Bai Yan,Guo Jiao,Su Zhengquan

Funder

2020 High Value Patent Cultivation Layout Center Project of Guangdong, China

Science Foundation for Distinguished Young Scholars of Guangdong

Science and Technology Program of Guangzhou, China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference229 articles.

1. Prognostic significance of the systemic inflammatory and immune balance in alcoholic liver disease with a focus on gender-related differences;Ahlenstiel;PLoS One,2015

2. Pharmacological inhibition of CCR2/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice;Ambade;Hepatology,2019

3. Role of transcription factors in steatohepatitis and hypertension after ethanol: The epicenter of metabolism;Ansari;Biomolecules,2016

4. Immunotherapeutic approaches of IL-1 neutralization in the tumor microenvironment;Apte;Journal of Leukocyte Biology,2017

5. Novel NF-κB inhibitors: A patent review (2011–2014);Arepalli;Expert Opinion on Therapeutic Patents,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3